Several authors have highlighted how the risk for ketoacidosis with an SGLT2-i “may be increased in long-standing T2DM patients with marked β-cell insufficiency or in latent autoimmune diabetes in adults with rapid evolution toward T1DM” [65]. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.